Advertisement
Canada markets open in 6 hours 22 minutes
  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CAD/USD

    0.7297
    -0.0004 (-0.06%)
     
  • CRUDE OIL

    83.02
    +0.17 (+0.21%)
     
  • Bitcoin CAD

    91,076.39
    -67.22 (-0.07%)
     
  • CMC Crypto 200

    1,401.43
    -13.33 (-0.94%)
     
  • GOLD FUTURES

    2,315.70
    -30.70 (-1.31%)
     
  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     
  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     
  • NASDAQ futures

    17,351.25
    +1.25 (+0.01%)
     
  • VOLATILITY

    16.94
    -1.77 (-9.46%)
     
  • FTSE

    8,023.87
    0.00 (0.00%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6850
    0.0000 (0.00%)
     

Merck to supply up to 1 mln courses of COVID-19 pill to Canada

Dec 3 (Reuters) - Merck & Co said on Friday it would supply the Canada with up to 1 million courses of molnupiravir, its experimental oral antiviral medicine for the treatment of COVID-19.

The government of Canada has secured access to 500,000 courses in 2022, with options for up to 500,000 more, pending Health Canada's approval, the company said. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Amy Caren Daniel)